drugset / Trial / NCT01213433

Amodiaquine+Artesunate for Uncomplicated Malaria Treatment

NCT01213433

NaSingle-groupOpen-labelTreatment

Summary

This is a phase IV one-arm study aiming at recruiting 50 patients to assess the efficacy of AQ+AS in patients with a positive RDT diagnosis of malaria in Nanoro, Burkina Faso.

Timeline

Start
2010-10
Primary completion
2010-11
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate-amodiaquine Unknown

Indications